GOLD STANDARD DIAGNOSTIC TEST FOR DENDUE
gold standard diagnostic test dengue fever NS1 RT-PCR serology
| Test | Window | Details |
|---|---|---|
| IgM capture ELISA (MAC-ELISA) | Day 3-5 onwards; 99% positive by day 10 | Standard for late/convalescent phase |
| IgG ELISA | Persists for life | Useful for secondary infections; can cross-react with other flaviviruses |
| Haemagglutination Inhibition (HI) Assay | Convalescent | Classically called "gold standard" for serology; 4-fold rise confirms infection |
| Complement Fixation (CF) / Neutralization Test | Convalescent | Less commonly used now |
Combine NS1 antigen + IgM ELISA on a single serum specimen taken in the first 10 days - this identifies ≥90% of both primary and secondary dengue cases.
| Phase | Days of Illness | Gold Standard Test |
|---|---|---|
| Early febrile | Days 1-5 | RT-PCR (gold standard) + NS1 Ag detection |
| Late febrile / early defervescence | Days 5-10 | NS1 + IgM ELISA |
| Convalescent | >Day 10 | IgM ELISA (MAC-ELISA); 4-fold IgG rise (HI assay) |
| Confirmation / reference standard | Any time | Viral isolation (historical); RT-PCR (practical) |
WHAT IS IgM ELISA
IgM ELISA MAC-ELISA principle dengue diagnosis explained
https://www.cdc.gov/dengue/hcp/diagnosis-testing/serologic-t…
ELISA principle sandwich IgM antibody detection diagram

This medical laboratory diagram illustrates a sandwich Enzyme-Linked Immunosorbent Assay (ELISA) technique used for the detection of VHH (variable heavy-chain antibodies). The schematic depicts the spatial arrangement of the assay components within a microtiter plate well from bottom to top: (a) A capture layer consisting of Rabbit anti-VHH polyclonal antibodies (pAb), which are passively adsorbed to the bottom of the well. (b) The analyte, represented as an HA-tagged VHH molecule, where the VHH core binds to the capture antibody and an HA (hemagglutinin) tag is available for detection. (c) The detection layer featuring an HRP-labeled anti-HA monoclonal antibody (mAb). This antibody targets the HA tag of the analyte and is conjugated to Horseradish Peroxidase (HRP), shown as a purple star-shaped molecule. At the top, a blue curved arrow labeled TMB (3,3′,5,5′-Tetramethylbenzidine) represents the chromogenic substrate added to the well. The diagram demonstrates the biochemical principle of signal transduction where HRP catalyzes the oxidation of TMB to produce a measurable colorimetric signal, indicating the presence and concentration of the VHH analyte.

This pathophysiology diagram illustrates the principles of ELISA-like sandwich immunosensors for protein detection. The schematic compares two diagnostic methods: (A) Single label and (B) Multi-label, higher sensitivity. Both assays utilize a solid-phase 'detection element' (black base) containing gold nanoparticles (AuNP) and immobilized Y-shaped 'Capture Antibodies' (blue). In method A, a single target 'Protein analyte' (purple circle) is sandwiched between the capture antibody and a 'Detection Antibody' (Ab2) conjugated to a single enzyme label. In method B, the detection antibody is part of a 'Multi-enzyme-magnetic particle' complex, featuring a large spherical carrier coated with numerous enzymatic labels (red dots). This configuration facilitates signal amplification for increased sensitivity. The diagram highlights key biochemical components including antibody-antigen binding dynamics and labeling strategies for optical or electrochemical clinical assays used in biomarker detection, such as cancer diagnostics. Labels identify key elements: Ab2-enzyme, AuNP, Capture Antibody, Protein analyte, and Multi-enzyme-Magnetic particle-Ab2.

This schematic diagram illustrates a specialized, blocking-free 'sandwich' Enzyme-Linked Immunosorbent Assay (ELISA) utilizing a polyethyleneimine (PEI) and gold nanoparticle (Au NP) coated microwell plate. The process is divided into two phases: preparation and detection. In the preparation phase, a microwell undergoes PEI incubation followed by Au NP incubation to form a functionalized base layer; capture antibodies are then immobilized onto the Au NPs. In the detection phase, labeled as a 'No blocking - One step' procedure, the antigen and horseradish peroxidase (HRP)-conjugated antibody are introduced. The final step shows the addition of TMB substrate, which undergoes a visual transition from a colorless liquid to a blue-colored solution, indicating successful antigen detection. The diagram highlights that this modified protocol simplifies traditional ELISA by omitting the 2-hour blocking step, reducing total assay time to less than 2 hours. Chemical structures for PEI and icons for antigens, Au NPs, and various antibodies are included to clarify the molecular binding sequence and surface modifications.
| Word | Meaning |
|---|---|
| Enzyme-Linked | An enzyme is attached to an antibody as a label/reporter |
| Immunosorbent | Antibodies or antigens are "adsorbed" (bound) onto a solid surface (microplate) |
| Assay | A test or measurement |

| Step | What Happens |
|---|---|
| 1. Capture | Microplate wells are coated with anti-human IgM antibody (captures all IgM from the patient sample) |
| 2. Patient sample added | Diluted patient serum is added - all IgM (including dengue-specific IgM) is captured onto the plate |
| 3. Dengue antigen added | Dengue viral antigen is added - it binds ONLY to dengue-specific IgM captured on the plate |
| 4. Enzyme-conjugated antibody | An anti-dengue antibody linked to HRP enzyme is added - it binds the dengue antigen |
| 5. Substrate added | TMB substrate is added - HRP converts it producing a yellow color |
| 6. Read result | Absorbance measured at 450 nm; positive = color change above cutoff |
| Feature | Details |
|---|---|
| When does IgM appear? | 3-5 days after onset of fever |
| When does it peak? | ~2 weeks after onset |
| When does it decline? | Falls to undetectable over 2-3 months |
| 99% patients IgM positive by... | Day 10 of illness |
| Sensitivity (days 5-10) | ~47-80% (varies by study) |
| Best combined strategy | NS1 + IgM MAC-ELISA on a single specimen (days 1-10) - detects ≥90% of cases |
| Primary Infection | Secondary Infection | |
|---|---|---|
| IgM | High levels, appears day 3-5 | Lower levels, may be undetectable |
| IgG | Appears later (day 14+), low titers | Rapidly rises to very high titers |
| IgM/IgG ratio | High (>1.2) | Low (<1.2) |
| Clinical significance | Milder disease usually | Higher risk of dengue hemorrhagic fever (DHF) |
Day 0-1: Fever onset
Day 1-5: RT-PCR + NS1 Ag ← Use these (IgM negative)
Day 3-5: IgM begins to appear
Day 5-10: NS1 + IgM ELISA ← Best window for combined testing
Day 10+: IgM ELISA alone (NS1 may be declining)
Months: IgG only (IgM gone, IgG persists for life)
GOLD STANDARD DIAGNOSTIC TEST FOR ANRMIA WHICH OCCURS DURING DENGUE INFECTIONS
gold standard diagnostic test anemia dengue infection hemolysis bone marrow
| Mechanism | Type of Anemia | Primary Cause |
|---|---|---|
| Bone marrow suppression | Hypoproliferative/aplastic-like | Direct viral invasion of bone marrow precursors |
| Hemolysis | Hemolytic anemia | Autoimmune (polyclonal antibodies vs RBC antigens) + complement activation |
| Hemorrhage (DHF/DSS) | Acute blood loss anemia | Plasma leakage, thrombocytopenia, mucosal bleeding |
| Hemodilution | Dilutional anemia | Plasma leakage causes hemoconcentration (opposite effect = raised Hct) |
"The direct antiglobulin test (DAT) or Coombs test is useful in revealing cells coated with antibody or complement and can aid in diagnosis. A positive DAT alone, however, does not define AIHA and must be supported by clinical context and evidence of hemolysis on laboratory evaluation."
| Test | What It Shows | Finding in Hemolysis |
|---|---|---|
| Peripheral blood smear | Morphology of RBCs | Spherocytes, schistocytes, fragmented RBCs |
| Reticulocyte count | Bone marrow compensatory response | Elevated (reticulocytosis) = RBCs being destroyed, marrow trying to compensate |
| LDH (Lactate Dehydrogenase) | Released from destroyed RBCs | Elevated |
| Haptoglobin | Binds free hemoglobin | Decreased (consumed by free Hb) |
| Indirect bilirubin | Breakdown product of heme | Elevated |
| Urine hemosiderin / hemoglobinuria | Intravascular hemolysis marker | Present in severe intravascular hemolysis |
Standard haematological parameters such as platelet count and haematocrit are important and are part of the diagnosis of dengue infection and should be closely monitored.
Step 1: CBC + Reticulocyte count + Peripheral Blood Smear
↓
Step 2: LDH + Haptoglobin + Indirect Bilirubin
↓
Evidence of hemolysis?
YES → Direct Coombs Test (DAT) ← GOLD STANDARD for immune hemolysis
NO → Check bone marrow / blood loss
↓
Step 3 (if bone marrow suppression suspected):
Bone Marrow Aspiration + Biopsy ← GOLD STANDARD for BM suppression
| Type of Anemia in Dengue | Gold Standard Test |
|---|---|
| Immune hemolytic anemia (most common) | Direct Antiglobulin Test (DAT / Direct Coombs) |
| Bone marrow suppression | Bone Marrow Aspiration and Biopsy |
| Blood loss anemia (DHF/DSS) | CBC + Hematocrit (with clinical context) |
| Overall initial screening | Complete Blood Count (CBC) + Peripheral Blood Smear |